The IL-33/ST2 axis and vitamin D as a possible emerging therapeutic target in osteoarthritis

Maria Maddalena Sirufo^{1

2}, Lia Ginaldi^{1

2}, Massimo De Martinis^{1

2}

Affiliations

¹ Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
² Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04, Teramo, Italy.

Comment

Maria Maddalena Sirufo et al. Rheumatology (Oxford). 2021.

. 2021 Aug 2;60(8):e300.

doi: 10.1093/rheumatology/keab292.

Maria Maddalena Sirufo^{1

2}, Lia Ginaldi^{1

2}, Massimo De Martinis^{1

2}

¹ Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
² Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04, Teramo, Italy.

No abstract available

Comment on

Development of medical therapeutics in osteoarthritis: time for action to improve patient care.
Sofat N, Watt FE, Tan AL. Sofat N, et al. Rheumatology (Oxford). 2021 Aug 2;60(8):3487-3489. doi: 10.1093/rheumatology/keab263. Rheumatology (Oxford). 2021. PMID: 33715006 Free PMC article. No abstract available.